Unique ID issued by UMIN | UMIN000029130 |
---|---|
Receipt number | R000033310 |
Scientific Title | Effects of green tea catechins on cholesterol synthesis/absorption markers in Japanese adults: a single-arm, open-label trial. |
Date of disclosure of the study information | 2017/10/23 |
Last modified on | 2018/03/15 09:35:21 |
Effects of green tea catechins on cholesterol synthesis/absorption markers in Japanese adults: a single-arm, open-label trial.
Effects of green tea catechins on cholesterol synthesis/absorption markers in Japanese adults: a single-arm, open-label trial.
Effects of green tea catechins on cholesterol synthesis/absorption markers in Japanese adults: a single-arm, open-label trial.
Effects of green tea catechins on cholesterol synthesis/absorption markers in Japanese adults: a single-arm, open-label trial.
Japan |
Borderline hyper LDL cholesterolemia
Cardiology | Adult |
Others
NO
The aim of this study is to investigate effects of the intake of green tea catechins on cholesterol synthesis/absorption markers.
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
Cholesterol synthesis and absorption markers(0, 4, and 8 wk)
1) Synthesis/absorption(0, 4, and 8 wk)
2) LDL-cholesterol(0, 4, and 8 wk)
3) HDL-cholesterol(0, 4, and 8 wk)
4) Total cholesterol(0, 4, and 8 wk)
5) LDL/HDL(0, 4, and 8 wk)
6) Correlation between changing rate of LDL-cholesterol and changing rate of each of cholesterol absorption and synthesis markers from baseline to 8 weeks
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Prevention
Food |
A green tea beverage was given twice a day at mealtimes for 8 weeks.
20 | years-old | <= |
Not applicable |
Male and Female
1) Subjects judged to be appropriate by the responsible physician
2) Subjects have a higher LDL- cholesterol in screening test (the responsible physician may exclude subjects with extremely low cholesterol absorption markers )
1) A history of malignant tumor, heart failure, or myocardial infarct
2) Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia or hypertension
3) Subjects use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily
4) Currently taking medicines and/or herbal medicine
5) Those who are allergic to medicines and/or the test food related products
6) Pregnant, subjects with lactation period, or subjects having the mind to become pregnant in the test period
7) Subjects who participated in other clinical tests in 3 months before writing informed consent of this study was obtained
8) Subjects who are inadequate for enrollment judged by the responsible physician
20
1st name | |
Middle name | |
Last name | Yuko Sagesaka, PhD |
ITO EN, Ltd.
Central Research Institute
21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan
0548-54-1247
y-sagesaka@itoen.co.jp
1st name | |
Middle name | |
Last name | Makoto Kobayashi, PhD |
ITO EN, Ltd.
Central Research Institute
21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan
0548-54-1247
m-kobayasi@itoen.co.jp
Central Research Institute, ITO EN, Ltd.
None
Self funding
Orthomedico Inc.
None
NO
医療法人社団盛心会 タカラクリニック
2017 | Year | 10 | Month | 23 | Day |
Unpublished
Completed
2017 | Year | 09 | Month | 12 | Day |
2017 | Year | 09 | Month | 13 | Day |
2017 | Year | 12 | Month | 23 | Day |
2018 | Year | 01 | Month | 15 | Day |
2018 | Year | 02 | Month | 01 | Day |
2018 | Year | 02 | Month | 28 | Day |
2017 | Year | 09 | Month | 13 | Day |
2018 | Year | 03 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033310